Member Info for fatprofits

I give very few Strong Buys, however following the recent

trading Update and a chunky Director Buy,

Coats looks value.

I also like the comment from the CEO about winning work

from their competitors.

My 3 year price target is £1.10 a share.

Nice exposure here to 5g rollout - yes

Coats is also a performance materials company.

As always imv, please dyor.

77.80 or do you mean 78.70 ?.

£38 my ars* !!

You were standing at the station and the train done gone.

Hopefully some benfited from my previous post.

Looks tasty at these levels imv.

Monday, what a day.

May get some retrace.

Am I reading this correctly...net cash on the last update is well over £100 million??.

It's in the price and a gift of a price in the medium term.

Christmas has come early- all imv, dyor etc.

Mark, I take you point and perhaps should not have made a blanket
statement, although it is a significant factor imv.

For more context, if you look at a 5 year chart of GSK,
It is often given to these fat moves in either direction
and a good deal of that can be sentiment related.

Is for Luke Meils and Dr Hal Barron to replicate the success they enjoyed elsewhere,
Luke came from AZN, as people may be aware.

Yes, but would ignore that.

Look at Trump's statements on reducing drug costs in 2016/17.

Hot air.

Put simply, earnings are falling.

There are growth areas within the organisation, but no overall growth.

Advair, the last GSK blockbuster, is still contributing around £1 Billion of
revenue annually, that will likely continue to dwindle rapidly.

The last few years for GSK financially, have been about navigating
the Advair patent cliff.

That drug at it's peak contributed about 30% of GSK overall profitability.
Advair was an extraordinary contributer to the P& L.

I'm old enough to remember the giant patent cliff of Zantac,
which transformed GSK fortunes. Long time ago now.

apologies for the typos.

Edit function LSE, please.

Does everyone?, I dont think so. You don't.

I have also said my owm take is on an ...everything else brimg equal basis.

If the UKX falls 10% from here then take 10% from that etc, also the upcoming dividend
as it's about to trade XD.

Just a toe dip at under 13.92.

Next TuesdayI'm looking at as a possible better buy point to add.

* buying Zone

£12.50- 13 - very approx.

On saying that, it's on an all things being equal basis.

So if the UKX say, fell another 5% from current levels,

that range may also need to be adjusted downwards to reflect wider market levels.

I looked at Barclays yesterday for the first ever, at lesst seriously.

Withput the retail banking arm they would
be very interesting.

Very significant underperformance against Ping An and AIA

in share price terms.

Any views what is behind this?

I have serious asthma so well aware of Nucala, although luckily don't
need it.

Appreciate your reply.